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While once believed to represent a sterile environment, the human urinary tract harbors
a unique cellular microbiota. We sought to determine whether the human urinary tract
also is home to viral communities whose membership might reflect urinary tract health
status. We recruited and sampled urine from 20 subjects, 10 subjects with urinary tract
infections (UTIs) and 10 without UTIs, and found viral communities in the urine of each
subject group. Most of the identifiable viruses were bacteriophage, but eukaryotic viruses
also were identified in all subjects. We found reads from human papillomaviruses (HPVs)
in 95% of the subjects studied, but none were found to be high-risk genotypes that
are associated with cervical and rectal cancers. We verified the presence of some HPV
genotypes by quantitative PCR. Some of the HPV genotypes identified were homologous
to relatively novel and uncharacterized viruses that previously have been detected on
skin in association with cancerous lesions, while others may be associated with anal and
genital warts. On a community level, there was no association between the membership
or diversity of viral communities based on urinary tract health status. While more data
are still needed, detection of HPVs as members of the human urinary virome using viral
metagenomics represents a non-invasive technique that could augment current screening
techniques to detect low-risk HPVs in the genitourinary tracts of humans.
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INTRODUCTION
The presence of microbes inhabiting the human urinary tract has
generally been associated with urinary tract infections (UTIs),
but recent studies have demonstrated that the urine has its own
unique microbiota even in the absence of UTIs (Nelson et al.,
2010; Siddiqui et al., 2011; Wolfe et al., 2012). Many of these
microbiota may not be culturable using conventional culture
techniques, but the presence of a diverse microbiota in human
urine has highlighted the need to understand whether there is a
role for these communities of microbes in urinary tract health or
disease. Healthy female urinary microbiota often include organ-
isms also identified in the vagina (Fouts et al., 2012; Wolfe et al.,
2012; Hilt et al., 2014), while healthy male microbiota may resem-
ble the vagina, gut, and skin (Nelson et al., 2010; Dong et al.,
2011; Fouts et al., 2012). There are numerous lower urinary tract
symptoms that often do not have known infectious etiologies,
so understanding whether these conditions may be influenced by
disturbances to the urinary microbiota is of substantial interest.
UTIs are among the most common urological disorders in the
health care settings, and are diagnosed using a combination of
both symptoms and culture tests. Escherichia coli is recognized
as the most common etiological agent of UTI, responsible for
more than 80% of reported cases in females (Foxman and Brown,
2003), but there are numerous other microbes capable of causing
UTIs (Stamm, 2002; Pour et al., 2011; Volkow-Fernandez et al.,
2012). While a threshold concentration of 103 Colony Forming
Units (CFU) per ml of urine accompanied with lower urinary
tract symptoms is required for a UTI diagnosis, there are some
pathogens that are not detected by standard microbiological cul-
ture techniques (Rubin et al., 1992). Disturbances to the urinary
tract microbiota can be recognized in the presence of pathogens
(Pearce et al., 2014), but it is not yet clear how long it takes
for the urinary tract to recover its normal microbiota after both
pathogen-mediated disturbances and antibiotic therapy.
While there is a substantial cellular microbiota indigenous to
the human urinary tract, little is known about viruses. There
are viral pathogens of the human urinary tract, such as aden-
ovirus (Echavarria et al., 1998; Echavarria, 2008) and BK virus
(Shinohara et al., 1993; Paduch, 2007; Egli et al., 2009), but these
viruses generally are only pathogenic in subjects with compro-
mised immune systems. There are other viruses such as Human
papillomaviruses (HPVs) that inhabit human genital and rectal
areas, and have previously also been found in urine (Pathak et al.,
2014). Because HPVs can be associated with both warts and can-
cer in humans (Wylie et al., 2012), the diagnosis of its presence
and particular subtypes associated with infection can be criti-
cal in the care of individual subjects who are infected. Previous
studies have demonstrated that robust communities of cellular
microbiota on human body surfaces are generally accompanied
by communities of viruses. There are vast communities of viruses
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that inhabit the human oral cavity (Pride et al., 2012; Abeles et al.,
2014; Ly et al., 2014), the human gut (Minot et al., 2011), the
human respiratory tract (Willner et al., 2009), and human skin
(Foulongne et al., 2012), which suggests that there likely would be
communities of viruses that also are indigenous to the human uri-
nary tract. One prior study identified a unique viral community
in the subgingival crevice of individuals with severe periodontal
disease (Ly et al., 2014), which suggests that viruses could play a
role in health and disease. There are many subjects with lower uri-
nary tract symptoms, with no known cellularmicrobial etiologies,
yet viral communities in these subjects are completely unexplored
(Enerly et al., 2013).
We sought to decipher whether there is a population of viruses
indigenous to the human urinary tract and whether urine viral
community membership may be affected by urinary tract health
status. Our goals were to: (1) identify and quantify viral popu-
lations in human urine, (2) determine whether trends in urine
bacterial biota might also be reflected in the virobiota of urine, (3)
elucidate whether the presence of urinary pathogens affects viral
community membership, (4) decipher whether human viruses
populate the urinary tract, or whether viruses encountered are
primarily bacteriophage, and (5) characterize differences between
the virobiota of the male and female urinary tracts.
MATERIALS AND METHODS
HUMAN SUBJECTS AND CULTURE CONDITIONS
Human subject involvement in this study was approved by the
University of California, San Diego Administrative Panel on
Human Subjects in Medical Research. The study was certified
as category 4 exempt, which includes research involving the
collection or study of existing data, documents, records, patho-
logical specimens, or diagnostic specimens, if the information
is recorded in such a manner that subjects cannot be identified,
directly or through identifiers linked to the subjects. We sam-
pled the urine from 20 human subjects, with 10 having urinary
tract infections, and another 10 testing negative for UTIs. None
of the female subjects had prior abnormal PAP smears and there-
fore had never been tested for the presence of cervical HPV. None
of the male subjects had anal PAP smears and were not previously
tested for HPV. No subjects reported any prior history of anal or
genital warts. The diagnosis of UTI was based on the clinical lab-
oratory standards institute definition, and includes the presence
of ≥ 103 CFU of bacteria and ≥10 leukocytes per high powered
field (Stamm, 1983). All specimens were planted on Sheep’s blood
agar,McConkey, and Chocolate agar plates. Each of the patients in
this study was symptomatic and had at least 103 CFU/ml of bacte-
ria in their urine specimens. Bacteria were identified to the species
level using Matrix-Assisted Laser Desorption Ionization Time of
Flightmass spectrometry, which is amass spectrometry technique
for the identification of bacteria with sensitivity and specificity
similar to that of conventional biochemical techniques (Neville
et al., 2011). For the E. coli isolates, their identification also was
verified by the presence of lactose fermentation and mobility to
ensure that they could not be Shigella species. Urine specimens
were processed within 2 h of their collection and the bacteria were
identified within 24 h of their collection. All specimens from both
UTI+ andUTI− subjects had their viromes processed within 48 h
of their collection. All cultures from UTI− subjects were held for
a minimum of 72 h to ensure they were truly negative. All urine
specimens were stored at 4◦C prior to processing of viromes.
VIROME PREPARATION AND SEQUENCING
Urine samples were processed according to our previously
described protocols for processing viruses from saliva (Pride
et al., 2012). Urine (1ml) was filtered sequentially using 0.45
and 0.2µm filters (VWR, Radnor, PA) and purified on a cesium
chloride density gradient, with the fraction corresponding to
most known bacteriophage (Murphy et al., 1995) retained.
The purified virions were further purified on Amicon YM-100
protein columns (Millipore, Inc., Bellerica, MA), treated with
DNase I, and their DNA purified using a Qiagen UltraSens
virus kit (Qiagen, Valencia, CA). DNA then was amplified using
GenomiPhi V2 MDA amplification (GE Healthcare, Pittsburgh,
PA), fragmented to 200–400 bp using a Bioruptor (Diagenode,
Denville, NJ), and libraries created using the Ion Plus Fragment
Library Kit. Libraries then were sequenced using 314 chips on an
Ion Torrent Personal Genome Machine (PGM; Life Technologies,
Grand Island, NY) (Rothberg et al., 2011) producing an average
read length of approximately 206 bp.
VIROME ANALYSIS
We trimmed the resulting reads according to modified Phred
scores of 0.5 using CLC Genomics Workbench 4.65 (CLC bio
USA, Cambridge, MA), removed any low complexity reads
(where >25% of the length were due to homopolymer tracts),
and removed any reads with substantial length variation (<50
nucleotides or >300 nucleotides) or ambiguous characters prior
to further analysis. Each virome was screened for contaminating
bacterial and human nucleic acids using BLASTN analysis (E-
score <10−5) against the Ribosomal Database Project 16S rRNA
database (Cole et al., 2009), and the human reference database
available at ftp://ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/. Any
reads homologous to human sequences were removed prior to
further analysis. GC content variation among contigs was assessed
using Box and Whiskers plots created using Microsoft Excel 2007
(Microsoft Corp., Redman, WA). Remaining reads were assem-
bled using CLCGenomicsWorkbench 4.65 based on 98% identity
with a minimum of 50% read overlap, which were more stringent
than criteria developed to discriminate between highly related
viruses (Breitbart et al., 2002). Because the shortest reads were 50
nucleotides, the minimum tolerable overlap was 25 nucleotides,
and the average overlap was no less than 103 nucleotides depend-
ing on the characteristics of each virome. The consensus sequence
for each contig was constructed according to majority rule, and
any contigs <200 nucleotides or with ambiguous characters were
removed prior to further analysis. Contigs were annotated using
BLASTX against the NCBINon-redundant (NR) database with an
E-score cutoff value of 10−5. Specific viral homologs were deter-
mined by parsing BLASTX results for known viral genes including
replication, structural, transposition, restriction/modification,
hypothetical, and other genes previously found in viruses for
which the E-score was at least 10−5. Each individual virome con-
tig was annotated using this technique; however, if the best hit
for any portion of the contig was to a gene with no known
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function, lower level hits were used as long as they had known
function and still met the E-score cutoff. The annotation data
were compiled for each subject and used to determine the relative
proportions of assembled contigs that contained viral homologs.
Analysis of shared homologs present in each virome was per-
formed by creating custom BLAST databases for each virome,
comparing each database with all other viromes using BLASTN
analysis (E-score <10−10). Beta diversity between viromes was
determined using binary Sorensen distances, and was determined
by randomly sampling 1000 contigs between viromes. Principal
coordinates analysis (PCOA) was performed with the estimated
distances using Qiime (Caporaso et al., 2010b). Read mappings
of viromes to a database of phage (www.phantome.org; ftp://ftp.
ncbi.nih.gov/genomes/Viruses/) and a database of viruses (ftp://
ftp.ncbi.nih.gov/genomes/Viruses/) was performed using CLC
Genomics Workbench 4.65 (CLC bio USA, Cambridge, MA), and
were mapped using 98% identity over a minimum of 50% of the
read length. Virome sequences are available for download in the
MG-RAST database (metagenomics.anl.gov/) under the project
“UrineViromeProject,” or under project #9680.
VIRAL DIVERSITY
To measure alpha diversity in the viral communities, we uti-
lized a technique termed the Homologous Virus Diversity Index
(HVDI). The technique is based on finding high levels of homol-
ogy amongst contigs within viromes that likely belong to the
same virus but were placed into separate contigs due to the lim-
itations of the assembly process (Abeles et al., 2014). Virome
reads were assembled using 98% identify over a minimum of
50% of the read length using CLC Genomics Workbench 4.65
(CLC bio USA, Cambridge, MA), and the resulting contig spectra
utilized as the primary input for the index. We created cus-
tom nucleotide BLAST databases for each subject that contained
all their contigs. We then used BLASTN analysis to find high
levels of homology (E-score <10−20) between different contigs
within the same subject. We accepted only high levels of homol-
ogy that spanned at least 50% of the length of the shorter contig
being compared. All contigs in each subject were treated as nodes
and those contigs that had high homology to other contigs in
the same subject were added to a network by directing edges
between the nodes. After evaluating homologies among all intra-
subject contigs, networks formed from directed edges/nodes were
assigned to individual viruses and nodes with no associations
were considered singular viruses. For each resulting network, we
added the number of reads assigned to each node on the net-
work and the combined number of reads was used to represent
the relative abundance of the virus represented by that network.
The relative abundances of all viruses were calculated using this
technique, and a new contig spectra representing the viral pop-
ulation in each subject was formed. The contig spectra from
each subject then were used as surrogates for population struc-
tures and input directly into the Shannon Index (Gotelli and
Colwell, 2001) to estimate diversity. We also utilized the relative
numbers of viral contigs created from only a single read (single-
ton) or from only two reads (doubleton) as input for the chao1
index (Chao, 1984). The results of the corrected contig spectra in
each case were compared with uncorrected contig spectra, and in
each case resulted in an approximate 10% reduction in diversity
calculations.
QUANTITATIVE PCR
We designed primers HPV49F (GTGATTCAAATGCAAGGG)
and HPV49R (TTTACAATCTCAGACCAGTG) to target HPV
genotype 49 and HPV178F (TGTTTGGAAGGGATCTAGT) and
HPV178R (TCATTAAAAAGCGCCAGG) to target HPV geno-
type 178. Primers for both genotypes were based on early gene
1 sequences. We performed quantitative PCR in 20µl reactions
using 10µl of SYBR Select Master Mix (Life Technologies, Grand
Island, NY), 1µl of template viral DNA (10 ng/µl), 7µl of ultra-
pure water, and 1µl (0.5 pmol) of each of the forward and reverse
primers. The following cycling parameters were used: an initial
denaturation at 95◦C for 2min, followed by 35 cycles at 95◦C for
15 s, annealing at 54◦C for 15 s, and final extension at 60◦C for
1min on an Eppendorf Mastercycler Realplex2. Each reaction was
run in triplicate and results were only considered positive if each
replicate had a Ct-value =35 with a product at the expected size.
One of the products was verified by Sanger sequencing of the PCR
amplicon and produced a product identical to the reads matching
HPV already found.
ANALYSIS OF 16S rRNA
Genomic DNA was prepared from the urine of each subject
and time point using the Qiagen QIAamp DNA MINI kit
(Qiagen, Valencia, CA). Each sample was subjected to a bead
beating step prior to nucleic acid extraction using Lysing Matrix-
B (MP Bio, Santa Ana, CA). We amplified the bacterial 16S
rRNA V3 hypervariable region using the forward primer 341F
(CCTACGGGAGGCAGCAG) fused with the Ion Torrent Adaptor
A sequence and one of 23 unique 10 base pair barcodes, and
reverse primer 514R (ATTACCGCGGCTGCTGG) fused with the
Ion Torrent Adaptor P1 from the urine of each subject (Whiteley
et al., 2012). PCR reactions were performed using Platinum
PCR SuperMix (Invitrogen, Carlsbad, CA) with the following
cycling parameters: 94◦C for 10min, followed by 30 cycles of
94◦C for 30 s, 53◦C for 30 s, 72◦C for 30 s, and a final elonga-
tion step of 72◦C for 10min. Resulting amplicons were puri-
fied on a 2% agarose gel stained with SYBR Safe (Invitrogen,
Carlsbad, CA) using the MinElute PCR Purification kit (Qiagen,
Valencia, CA). Amplicons were further purified with Ampure
beads (Beckman-Coulter, Brea, CA), and molar equivalents were
determined for each sample using a Bioanalyzer 2100 HS DNA
Kit (Agilent Technologies, Santa Clara, CA). Samples were pooled
into equimolar proportions and sequenced on 314 chips using
an Ion Torrent PGM according to manufacturer’s instructions
(Life Technologies, Grand Island, NY) (Rothberg et al., 2011).
Resulting sequence reads were removed from the analysis if
they were <130 nucleotide, had any barcode or primer errors,
contained any ambiguous characters, or contained any stretch
of >6 homopolymers. Sequences were assigned to their respec-
tive samples based on their 10 nucleotide barcode sequence, and
were analyzed further using the Qiime pipeline (Caporaso et al.,
2010b). Briefly, representative OTUs from each set were chosen
at a minimum sequence identity of 97% using UClust (Edgar,
2010) and aligned using PyNast (Caporaso et al., 2010a) against
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the Greengenes database (Desantis et al., 2006). Multiple align-
ments then were used to create phylogenies using FastTree (Li
and Godzik, 2006), and taxonomy was assigned to each OTU
using the RDP classifier (Wang et al., 2007; Price et al., 2009).
PCOA was performed based on Beta Diversity using weighted
Unifrac distances (Lozupone et al., 2006). Alpha diversity based
on the Shannon Index and the chao1 index also were performed
using the Qiime pipeline. Differences in the relative abundances
of taxa between subject groups were determined using student’s
t-test. 16S rRNA sequences are available for download in the
MG-RAST database (metagenomics.anl.gov/) under the project
“UrineViromeProject,” or under project #9680.
STATISTICAL ANALYSIS
To assess whether viromes had significant overlap between sub-
jects and subject groups, we performed a permutation test based
on resampling (10,000 iteration) (Robles-Sikisaka et al., 2013,
2014; Abeles et al., 2014; Ly et al., 2014; Naidu et al., 2014).
We simulated the distribution of the fraction of shared virome
homologs from two different time points within individual sub-
jects that were randomly chosen across all time points. For each
set, we computed the summed fraction of shared homologs using
1000 random contigs between randomly chosen individual time
points within different subjects, and from these computed an
empirical null distribution of our statistic of interest (the fraction
of shared homologs). The simulated statistics within each subject
group were referred to the null distribution of inter-group com-
parisons, and the p-value was computed as the fraction of times
the simulated statistic for the each exceeded the observed statistic.
An identical analysis was performed at the OTU level for the16S
rRNA taxonomic assignments. For analysis of sex specific charac-
teristics within the viromes, a randomly chosen subject and time
point from the male sex was compared with a randomly chosen
subject and time from the female sex to determine the null distri-
bution of fraction of shared contigs based on opposite sexes. We
then estimated the fraction of shared homologs from randomly
chosen subjects and time points within each sex and compared
with the empirical null distribution from simulated inter-sex val-
ues. We estimated the p-value based on the fraction of times the
intra-sex statistic exceeded that for the observed statistic.
RESULTS
HUMAN SUBJECT CHARACTERISTICS
We recruited 20 human subjects, 10 that were diagnosed with
UTIs and 10 with negative urine cultures (Table 1). The diagnosis
of UTI was made in the urine based upon the presence of ≥10
leukocytes per high powered field along with ≥103 CFU of bacte-
ria. Of those 10 subjects with UTI’s, eight grew E. coli, one grew
Enterococcus faecium, and one grew Acinetobacter baumanii com-
plex from their urine. Five of the subjects were male and five were
female in both arms of the study. We processed viromes from the
urine in each subject within 24 h of their collection to ensure that
viral structure and nucleic acid integrity would not be affected by
processing times.
EPIFLUORESCENCE MICROSCOPY
Because viral communities in human urine have not previously
been characterized, we first utilized epifluorescence microscopy
to determine whether viral communities were present and to
estimate their concentrations. We found that there were approx-
imately 107 virus-like particles (VLPs) per ml of urine present in
each of the subjects in this study (Supplemental Figure 1). No
differences in VLP concentrations were observed between sub-
jects with or without UTIs. Comparatively, there generally are 108
VLPs per ml of saliva (Pride et al., 2012) and 5 × 108 VLPs per ml
of human feces (Haynes and Rohwer, 2011). The relatively low
concentrations of viruses in urine may reflect the lower relative
abundance of the microbiota in the human urinary tract when
compared to the oral cavity and the gut. These data suggest that
there are communities of viruses present in the human urinary
tract whose relative abundance are not affected by the presence of
urinary pathogens.
URINE VIROME SEQUENCE CHARACTERISTICS
We isolated viral communities from the urine of our cohort
using our previously described methods (Robles-Sikisaka et al.,
2013, 2014; Abeles et al., 2014; Ly et al., 2014; Naidu et al.,
2014). We sequenced a total of 14,542,349 reads, 6,734,864 from
subjects with UTIs and 7,807,485 from subjects without UTIs
(Supplemental Table 1). The mean number of reads per sub-
ject was 727,117, with a mean length of 206 nucleotides, and
a mean GC content of 40.1%. Viromes were screened for con-
taminating cellular DNA by BLASTN (E-score <10−5) analy-
ses against the Ribosomal Database Project 16S rRNA database
(Cole et al., 2009) and a Human Reference Genome database
(ftp://ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/). None of the
viromes had identifiable 16S rRNA, and 0.42% of the reads were
homologous to human DNA. Reads homologous to human DNA
were removed prior to further analysis. We assembled the viral
reads into contigs, as the larger contigs generally result in more
productive BLAST searches. We obtained an average of 2285 con-
tigs per subject with a mean length of 1209 nucleotides and
a mean GC content of 41.4%. No significant differences were
observed in GC content between subjects with and without UTIs
(Supplemental Figure 2).
DETECTION OF HUMAN PAPILLOMAVIRUSES (HPVs)
To decipher whether theremay be individual viruses in this cohort
that have high similarity to known viruses, we mapped the reads
from each virome to the NCBI virus database. We found reads in
both UTI+ and UTI− subjects that matched herpesviruses, poly-
omaviruses, and human papillomaviruses. The HPVs were much
more prevalent than any other eukaryotic viruses identified in
these subjects, and many of the viromes had reads that mapped
specifically across most of the genomes of the HPVs. Nineteen
of the 20 (95%) subjects mapped across different HPV viromes,
which included all UTI− subjects and nine of 10 (90%) of the
UTI+ subjects (Supplemental Table 2). For subject URN2, 1.7%
(14,647 reads) of the reads mapped to HPV Type 96 (Figure 1A),
and in subject URN6, 1.8% (13,948 reads) of the virome reads
mapped to HPV Type 49 (Figure 1B). Different reads from these
subjects alsomapped toHPVTypes 92, and 121 (data not shown).
In subject URP12, 3.7% (25,389 reads) of the reads mapped to
HPV Type 178 (Figure 1C) and Type 121 (data not shown). None
of the subjects participating in this study had previously been
diagnosed with genital warts or HPV infections, so the presence
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Table 1 | Study subjects.
Subjects Sex Age Symptoms Immuno compromiseda Organism Catheterb
NEGATIVE URINE CULTURES
URN1 Male 94 None No None No
URN2 Male 57 Sepsisc Yes None Yes
URN6 Male 51 Pain in prostate area No None Yes
URN9 Male 47 Pain with urination No None No
URN10 Female 27 Vaginal bleeding No None No
URN11 Female 31 Pain with urination No None No
URN12 Female 25 Abdominal pain No None No
URN13 Female 51 Urine odor Yes None No
URN15 Female 54 Sepsisc No None Yes
URN16 Male 72 None No None No
POSITIVE URINE CULTURES
URP1 Male 62 Urinary retention No E. coli No
URP2 Female 34 Sepsisc Yes E. coli Yes
URP3 Female 50 Stroke No E. coli No
URP4 Male 65 None No E. coli Yes
URP6 Female 18 Dysuria No E. coli No
URP7 Female 22 Autonomic instability No E. faecium Yes
URP9 Male 52 Sepsisc Yes E. coli No
URP10 Male 58 Sepsisc Yes Acinetobacter Yes
URP12 Male 78 Sepsisc Yes E. coli Yes
URP14 Female 69 Dysuria Yes E. coli No
aIncludes subjects with cancer and organ transplants, and those taking immunosuppressive medications such as steroids.
bIncludes subjects with catheters in their bladders and a single subject with a nephrostomy.
cPotentially life threatening complication of infection resulting in severe inflammation and blood pressure drops.
FIGURE 1 | Read mappings of select viromes to Human papillomaviruses
(HPVs). (A) Represents URN2 mapping to HPV Type 96, (B) represents
URN6 mapping to HPV Type 49, and (C) represents URP12 mapping to HPV
Type 178. The relative coverage of each contig is represented, along with
annotated open reading frames (ORFs) above each box. The portions of the
contigs identified are represented by the colored boxes for each subject. The
length of each contig is denoted at the top of each panel. The relative
proportions of reads mapping to each virus are represented in green.
of HPV in the urine of these subjects suggests that urine may
be a reasonable specimen type for screening for urogenital HPV
infections. None of the females had previously had abnormal PAP
smears or cervical HPV testing, but the types of HPVs identified
by commercially available tests would not have identified the
genotypes present in this study. To confirm the presence of some
HPV types in the urine, we developed primers for HPV Types 49
and 178, as several subjects had reads that mapped specifically
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to these viruses. We confirmed the presence of nucleic acids
matching HPV Type 49 in the urine of five of the 20 subjects
(Supplemental Figure 3), while 10% of the subjects had nucleic
acids matching HPV Type 178 (Figure 2).
FIGURE 2 | Bar graphs of the percentage of subjects with detectable
HPV Types 49 and 178 by quantitative PCR. White bars indicate those
subjects with negative urine cultures, and black bars represent subjects
with urinary tract infections.
IDENTIFICATION OF URINARY BACTERIOPHAGE
Viromes were also mapped against a phage database. We found
manyviral reads thatmapped to individual viruses, however,many
only mapped to single genes often involved in viral replication.
We did find some that mapped across much of the genomes of
knownviruses, includingsubjectURN2mappingtoLambdaphage
(Supplemental Figure 4A), URN12 mapping to Staphylococcus
phage PH15 (Supplemental Figure 4B), URP1 mapping to E. coli
phage phiV10 (Supplemental Figure 4C), and URP2 mapping to
Enterococcus phage phiFL4A (Supplemental Figure 4D).
To further aid in deciphering the contents of the viromes, we
subjected all the assembled contigs to BLASTX analysis against
the NCBI NR database to identify homologous sequences. We
identified numerous contigs with homologous sequences in the
NR database, with most of those sequences homologous to
phage. Approximately 27 percent of the contigs were homol-
ogous to known viruses, with the majority (>99%) representing
bacteriophage (Supplemental Figure 5). We identified contigs
with homologs to viral hypothetical proteins, structural genes
(head, capsid, collar, portal tail, tail fibers), restriction modifi-
cation enzymes, virulence and DNA replication and integration
genes (DNA polymerases, helicases, integrases, and primases)
(Figure 3). No significant differences were noted for the viral
gene categories in association with urological health status. The
high proportions of integrases identified (Figure 3) suggests that
viruses with primarily lysogenic lifestyles were abundant in the
urine viromes.
FIGURE 3 | Bar graphs of the mean percentages of contigs (± standard error) with viral homologs in the NR database from all of the subjects. White
bars indicate those subjects with negative urine cultures, and black bars represent subjects with urinary tract infections.
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ALPHA DIVERSITY AMONGST URINARY MICROBIOTA
Wedeterminedthealphadiversitypresent in theurinaryviromes to
determine if significant differences exist between subjects based on
FIGURE 4 | Rarefaction analysis based on the Homologous Virus
Diversity Index using the Shannon Index (A) and the chao1 Index (B)
for urine viral communities. The index values are shown on the y-axis and
the number or reads sampled are shown on the x-axis. White boxes
indicate those subjects with negative urine cultures, and black triangles
represent subjects with urinary tract infections. Dashed lines indicate those
subjects with negative urine cultures, and solid lines represent subjects
with urinary tract infections.
urinary tract health status andas ameasureof the relative adequacy
of our sequencing depth.Weperformed rarefaction analysis on the
urinary viromes based on the Homologous Virus Diversity Index
(HVDI) (Santiago-Rodriguez et al., under review) to determine
the adequacy of our sequencing depth. We first calculated the
HVDI based on the Shannon Index (Figure 4A), which indicated
thatmost of the diverse viruses present in the community hadbeen
sampled with relatively minimal sequencing efforts. The index
calculated based on the chao1 index (Figure 4B) approached
asymptote for most urine samples, which corroborates that the
sequencing depth for these urinary viromes was adequate.
We also characterized the bacterial communities through anal-
ysis of the 16S rRNA V3-hypervariable region. We compared the
alpha diversity present in bacterial and viral communities using
the Shannon index for the bacterial biota. There were no observed
differences in viral community diversity based on urinary tract
health status (Figure 5A) (p = 0.729); however, bacterial diver-
sity was substantially lower in subjects with UTIs (Figure 5B)
(p = 0.059), probably reflecting the relative abundance of the uri-
nary pathogens present. That viral diversity is unaffected despite
differences in bacterial biota, suggests that the urinary pathogens
may not contribute substantially to overall viral diversity.
BETA DIVERSITY IN URINARY MICROBIOMES
To decipher whether there may exist differences in virome com-
munity membership based on urinary tract health status, we
compared beta diversity amongst the viromes and visualized pat-
terns of variation present using principal coordinates analysis
(Figure 6A). We did not observe any patterns of variation in the
viromes that were attributable to health status. We did, however,
identify substantial differenceswhenexamining thebacterial biota,
where those subjects with UTIs formed a somewhat homogenous
cluster (Figure 6B). We previously have identified host-sex spe-
cific characteristics of viral communities in human saliva (Abeles
et al., 2014), and we tested whether there may be specific traits
of the virobiota of urine that might also be host-sex specific.
For the viral communities, no host-sex specific differences were
identified for viral communities (Supplemental Figure 6).
FIGURE 5 | Plots of alpha diversity for urine viromes (A) and bacteria
biota using 16S rRNA (B). Viral diversity was determined using the
Homologous Virus Diversity Index based on the Shannon Index, and bacterial
diversity determined using the Shannon Index. White diamonds indicate
those subjects with negative urine cultures, and black diamonds represent
subjects with urinary tract infections.
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FIGURE 6 | Principal coordinates analysis of beta diversity of the urine viromes (A), and bacterial biota using 16S rRNA (B). White circles indicate
those subjects with negative urine cultures, and black circles represent subjects with urinary tract infections.
Table 2 | Viral homologs and shared 16S OTUs within and between
subject groups.
Percent homologous Percent homologous p-Valueb
within groupa between groupsa
BY URINE HEALTH STATUS
Viromes
UTI− 24.14±4.86 23.73±4.34 0.453
UTI+ 23.79±4.51 23.70±4.32 0.512
16S rRNA
UTI− 84.02±19.05 73.36±27.23 0.343
UTI+ 87.29±16.36 73.60±27.12 0.301
BY SEX
Viromes
Male 23.28±3.93 23.64±4.44 0.524
Female 24.66±4.63 23.74±4.48 0.424
16S rRNA
Male 88.47±10.82 75.42±25.99 0.377
Female 76.55±27.72 76.26±25.48 0.470
aBased on the mean of 10,000 iterations. Thousand random contigs were
sampled per iteration.
bEmpirical p-value based on the fraction of times the estimated percent
homologous contigs or shared OTUs for each group exceeded that between
groups.
We utilized a permutation test to determine whether the
proportion of homologous viral contigs among subjects with
UTIs was greater than would be expected to occur by chance
(Abeles et al., 2014; Ly et al., 2014). Similar to the results for the
PCOA (Figure 6A), there were no significant differences observed
for virome community membership by urinary tract health status
(Table 2). While the differences were not statistically significant,
thereweremore shared bacterialOTUs amongst the subjects based
on their urinary tract health status. There were no significant
differences for viromes or the bacterial biota based on host sex.
BLAST HITS AND BACTERIAL TAXONOMIES
We characterized the BLASTX hits for each virus homolog by
the taxonomy of the host bacteria at the Phylum level. While
this type of characterization does not provide accurate identi-
fication of the putative hosts for each viral homolog, it can be
utilized comparatively to understand whether virome homologs
might reflect 16S rRNA taxonomies. By characterizing the viral
communities in this manner, we find that BLASTX hits to
Proteobacteria are most predominant, followed by Bacteroidetes,
Actinobacteria, Verrucomicrobia, and Firmicutes (Figures 7A,B
andSupplemental Figure 7).TheBLASTXhitswere similar regard-
less of urinary tract health status,which again suggests that urinary
tract health does not determine virome community membership.
Trends in urine viral communities were not represented in the
bacterial taxonomies (Figures 7C,D).
DISCUSSION
Human body surfaces are inhabited by indigenous microbial
communities whose role in health and disease are just beginning
to be elucidated. The urine was once believed to constitute a sterile
environment, but studies now have determined that both the
male and female genitourinary tracts are home to viable bacterial
communities. We hypothesized that because these communities
are home to cellularmicrobes that theywould alsohave indigenous
communities of viruses, and this study is the first to demonstrate
that urine indeed has a robust community of viruses. We found
that there were approximately 107 VLPs in the urine of UTI+ and
UTI− subjects, which is an order of magnitude lower than we
have previously found in human saliva (Pride et al., 2012). This
may reflect differences in the relative abundances of bacteria in the
urine compared to the oral cavity, as the healthy human oral cavity
has many cultivable bacterial biota, while few are found in healthy
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FIGURE 7 | Pie charts of phage BLASTX hits (A,B) and bacterial
taxonomy using 16S rRNA (C,D). (A) and (C) represent subjects with
negative urine cultures, and (B) and (D) represent subjects with urinary
tract infections. The “∗” represents significant differences (p = 0.05)
between the proportions of different phyla represented between UTI+
and UTI− subjects.
urine. While many of the viruses identified were bacteriophage,
as has been demonstrated in many prior studies (Breitbart et al.,
2003; Willner et al., 2009, 2011; Reyes et al., 2010; Minot et al.,
2012; Pride et al., 2012; Ly et al., 2014; Naidu et al., 2014; Robles-
Sikisaka et al., 2014), the presence of HPVs, which are eukaryotic
viruses of the human host, suggests that human urine is a complex
community with numerous different indigenous virus genotypes.
Our methods to characterize viral communities generally have
not identified many enveloped viruses; however, we previously
have identified herpesviruses in the human oral cavity using these
methods (Pride et al., 2012; Ly et al., 2014), so the extent of any
biases imposed by using CsCl density gradient centrifugation
remains unclear. We focused our analysis of phage on the contigs
assembled from the virome reads because the longer contigs
allowed for more productive searches for homologous sequences,
but 73% of the contigs had no identifiable homologs. The analysis
of contigs did not identify many eukaryotic viruses because their
relatively low abundance and probable low diversity resulted in
few assembled contigs.
Many of our studies have found few eukaryotic viruses in the
oral microbiome when compared to the abundance and diversity
of bacteriophage (Pride et al., 2012; Robles-Sikisaka et al., 2013;
Abeles et al., 2014; Ly et al., 2014), suggesting that eukaryotic
viruses representa relatively smallproportionof thehumanvirome
(Wylie et al., 2012). In the present study we showed that HPVs
comprise a portion of the urine virome in some subjects regardless
of urinary tract health status. We were able to detect HPV Types
in 19 of the 20 (95%) subjects studied, suggesting that HPV may
be relatively common urinary virobiota. The HPV genotypes
identified in this study have not been associated with high risks
for cervical carcinomas, but Type 9 identified in some subjects
may be associated with the development of cutaneous cancers
(Andersson et al., 2012). Other subjectsmapped to Type 49, which
has been isolated from warts in renal transplant patients (Favre
et al., 1989), and Type 178, which was isolated from skin adjacent
to actinic keratosis (Johansson and Forslund, 2014; Martin et al.,
2014). Our results are among the first to demonstrate the presence
of these HPV genotypes in urine, presenting the opportunity to
further investigate their role in urological health and diverse
urological diseases. Unfortunately, the cohort of subjects studied
was not ideal for characterizing potential pathogenic effects of the
HPV genotypes identified because none had prior cystoscopies,
culposcopies, or body imaging to document bladder or cervical
pathology. Because the HPV genotypes in this study were not high
risk genotypes, cystoscopies and culposcopies were not clinically
indicated. Typical protocols for identifying HPV in women are
based on the presence of atypical cervical pathology (Nobbenhuis
et al., 1999), although primary HPV screening is now becoming
more prevalent (Whitlock et al., 2011). None of the females in
this study had prior abnormal PAP smears, and thus had not
been tested for HPV infections. HPV diagnostic tests in clinical
laboratories test for high risk genotypes (Ronco et al., 2010), and
would not have identified the genotypes found in this study. We
believe that most of the genotypes we identified probably may
be associated with genital warts, although none of the subjects
previously reported having genital warts.
We characterized the human urinary virome in association
with UTIs, as they are the most frequent cause of genitouri-
nary morbidity in adults (Resnick and Older, 1997; Foxman,
2003). It was somewhat surprising that the bacterial communi-
ties were significantly altered in UTI+ subjects (Figures 6, 7),
while there were no obvious differences observed in urine viral
communities. In the human oral cavity, we previously found
that both bacterial and viral communities were altered in sub-
jects with moderate/severe periodontal disease (Ly et al., 2014).
However, even when viral communities are composed mostly
of bacteriophage, their membership does not necessarily reflect
that of their host communities, likely due to different dynamic
relationships present for different host/phage pairs (Pride et al.,
2012). We believe that the lack of differences observed in UTI+
subjects may be secondary to the pathogens in these infections
contributing relatively few viruses to the urinary microbiota.
Further work would be necessary to decipher the contribu-
tion of phage from the pathogens in these subjects’ urine
microbiomes.
Similar to previous studies, there were identifiable differences
in bacteria taxa in associationwith urological health status (Pearce
et al., 2014). Urine from UTI− subjects exhibited higher bacterial
diversity when compared to UTI+ subjects (Figure 5B). These
differences were not observed for viral communities (Figure 5A),
as the pattern of BLASTX homologs in UTI+ and UTI− subjects
suggests that much of the viral community is conserved regardless
of urinary tract health status (Figures 7A,B). Recent work has
demonstrated that phage are capable of attaching to mucosal
surfaces (Barr et al., 2013), so it is possible that the viruses
observed in UTI+ patients could reflect viruses swept into the
urine frommucosal surfaces rather than actively replicating urine
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viruses. Study of the urinary tract transcriptome in a cohort of
UTI+ andUTI− patients could help elucidate whether the viruses
observed were actively transcribing/replicating.
The majority of the studies characterizing the urine micro-
biome in association with urological disorders focus on female
subjects, as lower urinary tract symptoms are more common
in adult females than males. Given anatomical differences in
male and female urinary tracts, it is feasible to hypothesize that
there would also be differences in the urinary microbiota. While
not meeting statistical significance, it was interesting that there
were differences identified in the bacterial biota of males and
females regardless of infection status (Table 2 and Supplemental
Figure 6). Much of the differences may reflect the uniqueness
of the female genitourinary tract, where the vagina also has its
own unique microbiota (Srinivasan et al., 2010) that potentially
overlaps with the urinary tract. Unlike our prior studies in the
human oral cavity (Abeles et al., 2014), there was no associa-
tion between host-sex and urine viral community membership
(Table 2 and Supplemental Figure 6). This study included only
20 subjects, which we used to screen for potential differences
in virome contents between the sexes. It remains a possibil-
ity that a much larger cohort could identify differences urine
viromes differences based on host sex. There appeared to be
substantial inter-individual variability between the viromes of
the subjects studied, however, we believe that longitudinal rather
than cross-sectional studies of human viromes provide a better
overview of variation observed between individuals (Abeles et al.,
2014).
Despite specific HPV types being associated with low and
high-health risks, just a fraction of the over 170 types have been
directly implicated with disease, and many may not be detected
using routine methods (Chaturvedi et al., 2011). Negative results
may lead to undiagnosed illnesses such as cancerous lesions; yet,
negative results have also been implicated with the existence of
novel HPV types that remain to be characterized and associated
with diverse disease phenotypes (Johansson et al., 2013). High-
throughput sequencing has been shown to successfully detect
several different HPV types in HPV-negative condylomas, sug-
gesting that it may be a reasonable approach to detect HPV in
HPV-negative specimens (Johansson et al., 2013). Our detection
of HPV genotypes in the urine viromes of 19 subjects whom
previously had not been diagnosed with HPV infections suggests
that HPV colonization of the urine may be relatively common.
That most viromes mapped across different HPVs, suggests the
viruses in our subjects share common features with multiple
known HPV genotypes. The data presented in this study indicate
that viral metagenomics on urine could augment current HPV
diagnostic approaches (Pathak et al., 2014).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be
found online at: http://www.frontiersin.org/journal/10.3389/
fmicb.2015.00014/abstract
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